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Abstract
Background: The definition of a hypothetical protein is a protein that is predicted to be expressed
from an open reading frame, but for which there is no experimental evidence of translation.
Hypothetical proteins constitute a substantial fraction of proteomes of human as well as of other
eukaryotes. With the general belief that the majority of hypothetical proteins are the product of
pseudogenes, it is essential to have a tool with the ability of pinpointing the minority of hypothetical
proteins with a high probability of being expressed.
Results: Here, we present an in silico selection strategy where eukaryotic hypothetical proteins
are sorted according to two criteria that can be reliably identified in silico: the presence of
subcellular targeting signals and presence of characterized protein domains. To validate the
selection strategy we applied it on a database of human hypothetical proteins dating to 2006 and
compared the proteins predicted to be expressed by our selecting strategy, with their status in
2008. For the comparison we focused on mitochondrial proteins, since considerable amounts of
research have focused on this field in between 2006 and 2008. Therefore, many proteins, defined
as hypothetical in 2006, have later been characterized as mitochondrial.
Conclusion: Among the total amount of human proteins hypothetical in 2006, 21% have later
been experimentally characterized and 6% of those have been shown to have a role in a
mitochondrial context. In contrast, among the selected hypothetical proteins from the 2006
dataset, predicted by our strategy to have a mitochondrial role, 53-62% have later been
experimentally characterized, and 85% of these have actually been assigned a role in mitochondria
by 2008.
Therefore our in silico selection strategy can be used to select the most promising candidates for 
subsequent in vitro and in vivo analyses.
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According to the Human Genome Organization
(HUGO), the human genome is predicted to consist of
19599 protein-encoding genes [[1], Human Genome
Project http://www.hugo-international.org/]. A substan-
tial part of these genes is predicted to encode a group of
proteins, where translation has not been demonstrated
and the proteins themselves have not been characterized.
This group of proteins is accordingly defined as hypothet-
ical. Although many of the listed hypothetical proteins
most likely are predicted products of pseudogenes, there
is a reasonable probability that a number of the listed
hypothetical proteins are truly novel and can perform
uncharacterized biological functions. Consequently, the
putative importance of hypothetical proteins is not negli-
gible.
Several in silico methods are available for descriptive pre-
dictions of proteins with unknown function. These
include studies of homology, database searches for
orthologs, or the presence of characterized functional
domains or motifs within the protein [2]. Most often false
positives will occur and predictions must be substantiated
by in vitro and/or in vivo experiments to validate and fur-
ther characterize predicted functionality. The in silico
methods are designed for functional prediction of a pro-
tein, but not specifically designed to ascertain whether a
protein is hypothetical or not. When screening hypotheti-
cal proteins for novel translatable candidates, in silico
methods are therefore rarely used and the researcher often
performs the screen with laborious in vitro and/or in vivo
experiments.
In the present study, we propose an in silico screening
strategy for eukaryotic systems, in which novel translata-
ble candidates can be selected from a group of hypotheti-
cal proteins. The strategy is based on in silico methods
normally used to make functional predictions of proteins,
which include search for presence of sub-cellular targeting
signals and for presence of characterized protein domains.
Especially targeting signals and, to a lesser extent, protein
domains can be predicted with high probability. The
occurrence of either targeting signals or identifiable pro-
tein domains can also be present in pseudogenes as a
result of gene duplication. However, we hypothesize that
the risk of a hypothetical protein being a pseudogene is
greatly reduced when both targeting signals and protein
domains are identified in the transcript, especially if the
protein domain architecture suggests a relevant function
in the predicted sub-cellular compartment. Selection of
hypothetical proteins based on a combination of both
these factors should therefore greatly increase the success
rate of discovering true functional proteins with roles in
subcellular compartments among hypothetical proteins.
Due to the design of the selection strategy it is ineffective
for identifying proteins without localization signals, and
this must be taken into consideration.
To exemplify our selection strategy we have chosen mito-
chondria as the targeted sub-cellular compartment.
Within recent years, a substantial amount of work has
been invested in compiling a near complete list of mito-
chondrial proteins in humans. This has resulted in the
establishment of the MitoCarta database http://
www.broad.mit.edu/pubs/MitoCarta/[3]. The total
number of genes encoding mitochondrial proteins is
according to MitoCarta at least 1013 [3]. Mitochondria
are semiautonomous organelles present in almost all
eukaryotic cells ranging from a single copy to several thou-
sands. Mitochondria contain their own autonomous
genome, which encodes 37 of these proteins. The remain-
der is encoded by nuclear DNA and imported into mito-
chondria. Examples of mitochondrial functions include
ATP production by oxidative phosphorylation, β-oxida-
tion of fatty acids, metabolism of amino acids and of lip-
ids. Furthermore, mitochondria have a prominent role in
apoptosis.
With the exception of proteins encoded by the mitochon-
drial genome, proteins are translated in the cytosol from
their corresponding mRNA. Many proteins are trans-
ported to specific parts of the cell where they function in
context of the sub-cellular compartment. The sub-cellular
localization of proteins can be facilitated by specific tar-
geting peptides. There are two types of targeting peptides,
the presequences and the internal targeting signals. Prese-
quences are often localized at the N-terminal whereas
internal targeting signals can be distributed throughout
the protein sequence [4-6]. The mitochondrial membrane
contains translocases for recognition and import of
nuclear-encoded mitochondrial proteins. The translocase
of the outer mitochondrial membrane (TOM complex) is
responsible for recognition and initial import of nuclear-
encoded mitochondrial proteins (reviewed in [7]). Mito-
chondrial precursor proteins posses either an N-terminal
presequence or internal targeting signals. Both types of
targeting peptides, N-terminal or internal, are recognized
by different import receptors of the TOM complex. N-ter-
minal presequences generally have a length of 6-85 amino
acid residues, enriched in Arg, Ser and Ala, while nega-
tively charged amino acids are rarely present [8]. N-termi-
nal presequences form positively charged amphiphilic α-
helices when bound to import receptors on the mitochon-
drial surface [9], and upon mitochondrial import, prese-
quences are removed by proteolysis (reviewed in [10,11]).
Even though binding of different parts of the TOM com-
plex to varying internal targeting signals has been shown
[12], a common motif for an internal targeting signal still
has to be elucidated,Page 2 of 9
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predict functional candidates among hypothetical pro-
teins we chose to focus on proteins with a predicted mito-
chondrial function. We have utilized an existing database
of hypothetical proteins assembled in 2006 [13]. From
this database we selected all hypothetical proteins pre-
dicted to be localized in human mitochondria due to the
presence of a putative mitochondrial N-terminal prese-
quence. These selected proteins were then investigated for
the presence of potentially functional protein domains.
We predict that the sub-group of hypothetical proteins,
with both a mitochondrial N-terminal presequence and
potentially functional protein domains has a high proba-
bility of being expressed and of having a function in a
mitochondrial context.
All proteins investigated were hypothetical in 2006. How-
ever, between 2006 and 2008, many proteins have been
experimentally characterized or removed from the data-
base as they have been proven to be products of pseudo-
genes. This increases the probability that the 2006 dataset
of hypothetical proteins includes a large number of pro-
teins that are now (as of 2008) classified as mitochon-
drial. By applying the selection strategy on the 2006
dataset, we are able to compare the resulting predictions
with the factual in vitro and/or in vivo characterizations of
the proteins performed from 2006 to 2008. Effectiveness
of the selection strategy can be demonstrated by compar-
ing proteins selected from the 2006 dataset with the
number of these proteins that, as of November 2008, are
demonstrated to be translated, mitochondrial or proven
to be pseudogenes.
Methods
We have utilized a database of proteins extracted from
GenBank in August 2006. At the time of extraction, all
proteins were defined as hypothetical and all sequences
were crosschecked and annotated [13]. In November
2008, the status of each individual protein was reinvesti-
gated and entries of the 2006 database that later have been
identified as duplicates were removed. The entries of the
2006 dataset were divided into three groups according to
their individual status in November 2008: Hypothetical
proteins, characterized proteins and proteins discovered
to be pseudogenes and therefore removed by GenBank.
These three groups are in the following collectively
referred to as the 2008 dataset.
Several prediction programs have been designed to pre-
dict the localization of eukaryotic proteins. In table 1, we
have listed a selection of available programs, which have
been reported to have a medium to high prediction accu-
racy [14-22]. To exemplify the occurrence of hypothetical
proteins with functional targeting peptides, hypothetical
proteins from the 2006 dataset were analyzed using pTar-
get. The pTarget program http://bioapps.rit.albany.edu/
pTARGET/ predicts protein targeting to nine different sub-
cellular locations including mitochondria. Prediction is
based on the occurrence of specific Pfam domains earlier
determined to be location specific. pTarget, can predict
68-87% of the true positives at accuracy rates of 96-99%
[19,20].
In contrast to pTarget, the TargetP program http://
www.cbs.dtu.dk/services/TargetP/ predicts mitochondrial
localization using the N-terminal sequence information
only, with a success rate of predictions of 90% [21]. Tar-
getP was used to screen the 2006 dataset for functional
mitochondrial targeting peptides.
All hypothetical proteins predicted to have a mitochon-
drial targeting peptide by TargetP, were further character-
Table 1: Overview of subcellular localization prediction programs for eukaryotic proteins
Classification method Number of localization sites Accuracy
BaCelLo [14]
http://gpcr.biocomp.unibo.it/bacello/
4-5 67-76%
LOCtree [15]
http://cubic.bioc.columbia.edu/services/loctree/
4 74%
MITOPRED [16]
http://bioapps.rit.albany.edu/MITOPRED/
1 85%
MultiLoc [17]
http://www-bs.informatik.uni-tuebingen.de/Services/MultiLoc/
11 75%
PA-SUB [18]
http://www.cs.ualberta.ca/~bioinfo/PA/Sub/
11 81-94%
pTarget [19,20]
http://bioapps.rit.albany.edu/pTARGET/
9 68-87%
TargetP [21]
http://www.cbs.dtu.dk/services/TargetP/
3 90%
WoLF PSORT [22]
http://wolfpsort.org/
12 80%
A selection of subcellular localization prediction programs for eukaryotic proteins reported to have a medium to high prediction accuracy. Listed 
are the numbers of compartments each program can predict targeting to, and the reported accuracy of the prediction.Page 3 of 9
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heidelberg.de/. The SMART program identifies protein
domains from a database of manually annotated known
protein domains [23,24].
We hypothesize that hypothetical proteins, predicted to
contain both a mitochondrial N-terminal presequence
and functional protein domains have a high probability
of being functional in a mitochondrial context. To verify
our hypothesis, we used the 2006 dataset of the, then,
hypothetical proteins. Using TargetP, we selected proteins
having a high probability of containing a mitochondrial
N-terminal presequence. For the resulting subset of pro-
teins we used SMART to search for the presence of func-
tional protein domains. Comparing with protein status
according to the 2008 dataset, we determined the percent-
age of selected proteins that had either been removed or
experimentally characterized after 2006. Furthermore, if
proteins had been experimentally characterized, we deter-
mined if they had been found to be functional in a mito-
chondrial context.
To demonstrate that the effectiveness of our in silico selec-
tion strategy is not dependent on neither TargetP nor the
SMART program, the localization prediction programs,
MITOPRED http://bioapps.rit.albany.edu/MITOPRED/
[16] and WoLF PSORT http://wolfpsort.org/[22] were
used in conjunction with the SMART program, to screen
the 2006 dataset for proteins predicted to be mitochon-
drial. MITOPRED and WoLF PSORT have been reported
to have high prediction accuracy of proteins that are local-
ized to the mitochondria. Prediction of localization is
based on the occurrence of Pfam domains and known
sorting motifs rather than the presence of mitochondrial
presequences as basis for prediction of protein targeting
[16,22]. The effectiveness of the selection strategy using
MITOPRED or WoLF PSORT was compared to the effec-
tiveness of the selecting strategy using TargetP. Corre-
spondingly, the effectiveness of our selection strategy was
investigated, when the SMART program was replaced with
the Prosite scanning tool http://www.expasy.ch/prosite/
[25]. Like the SMART program, Prosite identifies protein
domains from a database of manually annotated known
protein domains.
Results and discussion
After removing proteins found or predicted to be dupli-
cates of already existing proteins, the 2006 dataset of
hypothetical proteins contains 5860 proteins. According
to GenBank's current annotation (November 2008) of the
same group of proteins, 1455 of the 5860 proteins anno-
tated as hypothetical in 2006, are still hypothetical, while
1215 proteins have been experimentally characterized
and 3190 proteins have been removed by GenBank as
they have been identified as pseudogenes (See Additional
file 1).
pTarget was used to predict the distribution of human
hypothetical proteins from the 2006 dataset and the 2008
dataset (Table 2). pTarget is used to exemplify how
human hypothetical proteins can be sorted based on their
predicted cellular localization. This is important since our
selection strategy is limited to proteins targeted for a sub-
cellular localization. Using pTarget as an indicator only,
we are able to demonstrate that proteins predicted to be
localized to lysosomes, golgi, peroxysomes, mitochondria
or endoplasmic reticulum, comprise of 32% of the 2006
dataset. When including proteins predicted to be secreted,
proteins targeted for the plasma membrane or nucleus,
these include 87% of the 2006 dataset. This indicates that
the selection strategy, according to pTarget, can be applied
on up to 87% of the dataset.
TargetP predicts probability of mitochondrial localization
based solely on mitochondrial specific presequences.
These motifs do not necessarily require cis or trans acting
domains in order to be fully functional mitochondrial tar-
geting signals. Accordingly, if a hypothetical protein is
predicted to be localized to the mitochondria, there is a
reasonable probability that a corresponding, expressed
Table 2: Predicted subcellular distribution of human hypothetical proteins
Compartment Predicted subcellular distribution 2006 dataset 
(5860 proteins)
Predicted subcellular distribution 2008 dataset of 
hypothetical proteins (1455 proteins)
Nucleus 37% 36%
Cytoplasm 13% 14%
Plasma membrane 12% 8%
Lysosomes 9% 9%
Golgi 9% 11%
Peroxysomes 7% 10%
Extracellular/Secretory 6% 4%
Mitochondria 5% 5%
Endoplasmic reticulum 2% 3%
The protein localization prediction program pTarget was used to predict the subcellular localization of 5860 and 1455 hypothetical proteins from 
the 2006 and 2008 datasets respectively.Page 4 of 9
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it may still be the product of a pseudogene. Screening the
2006 dataset of human hypothetical proteins with TargetP
we found a total of 1139 proteins predicted to be localized
to mitochondria (See Additional file 1). TargetP places all
of the predicted proteins into reliability classes, ranging
from A to E, where A indicates the strongest prediction
[21]. We have focused on the total of 538 proteins belong-
ing to reliability class A (52 proteins), B (204 proteins)
and C (282 proteins) (See Additional file 1).
From reliability class A to C, 315 of 538 proteins (59%)
selected by TargetP, have been removed, while 75 of 538
proteins (14%) have been characterized and 32 of 538
proteins (6%) have been characterized as mitochondrial.
When focusing on proteins predicted by TargetP to be in
reliability class A, 15 of 52 proteins (29%) have been
removed, 18 of 52 proteins (35%) have been character-
ized and 14 of 52 proteins (27%) have been characterized
as mitochondrial (See Additional file 1). From the 2006
dataset of hypothetical proteins, 67 are listed in MitoCarta
as characterized mitochondrial proteins (See Additional
file 1). TargetP was successful in identifying 32 of the total
of 67 mitochondrial proteins, but did also select 315 pro-
teins that after 2006 have been removed by GenBank.
When focusing on proteins belonging to reliability class
A, 14 of 67 mitochondrial proteins were identified, while
15 proteins have been removed. This demonstrates that
TargetP is efficient in finding mitochondrial proteins, but
it is not suitable for screening hypothetical proteins for
novel translatable candidates. To be able to annotate the
selected hypothetical proteins we screened proteins from
reliability class A to C with the SMART program to deter-
mine the presence of known protein domains. We ignored
proteins only containing transmembrane domains, coiled
coil regions, signal peptides and/or segments of low com-
positional complexity, as these regions are not unique
protein domains.
Three groups of proteins were constructed from the 538
proteins investigated. Group I consists of 20 proteins, pre-
dicted by TargetP to belong to reliability class A and to
contain identifiable protein domains according to SMART
prediction. Group II consists of 56 proteins, predicted by
TargetP to belong to reliability classes A and B and to con-
tain identifiable protein domains. Group III contains 100
proteins that are predicted by TargetP to belong to reliabil-
ity classes A, B and C and to contain identifiable protein
domains. Group III therefore contains all proteins of
group I + II and group II contains all proteins of group I.
The construction of these three groups allows us to com-
ment on how reliable the prediction of cellular localiza-
tion should be in order to get a good result from our
selection strategy.
The three groups of selected proteins were, together with
the 5860 hypothetical proteins from the 2006 dataset,
compared with their corresponding 2008 annotations.
The comparison includes number of experimentally char-
acterized proteins, number of experimentally character-
ized mitochondrial proteins and number of proteins
removed due to being the predicted result of pseudogenes
or due to having similarity to an existing protein (Table
3).
25% of the 5860 proteins were in November 2008 still
annotated as hypothetical, 21% had been experimentally
characterized and 54% have been removed. Of the exper-
imentally characterized proteins, 67 proteins or 6% were
listed in MitoCarta as mitochondrial. Group III contains
100 proteins, where 36%, as of November 2008, are still
hypothetical, 53% have been characterized and 11% have
Table 3: Comparison of predicted versus experimentally determined status of proteins
Group Localization signal/
protein domain
Hypothetical 
proteins
Characterized 
proteins
Removed proteins Characterized 
mitochondrial 
proteins
I 20 30%
(6 of 20)
65%
(13 of 20)
5%
(1 of 20)
85%
(11 of 13)
II 56 27%
(15 of 56)
64%
(36 of 56)
9%
(5 of 56)
58%
(21 of 36)
III 100 36%
(36 of 100)
53%
(53 of 100)
11%
(11 of 100)
45%
(24 of 53)
2006 dataset - 25%
(1455 of 5860)
21%
(1215 of 5860)
54%
(3190 of 5860)
6%
(67 of 1215)
Hypothetical proteins from the 2006 dataset sorted into groups depending on the probability of having a mitochondrial N-terminal presequence 
localization signal. Proteins of Group I, have been predicted by TargetP to belong to reliability class A, indicating the strongest prediction. Proteins 
of Group II contain proteins belonging to reliability class A and B, while proteins of Group III contain proteins belonging to reliability class A, B and 
C. All proteins of Group I, II and III have identifiable protein domains according to SMART. The three groups have been compared with all 5860 
proteins of the 2006 dataset, and with their respective 2008 annotations, to evaluate whether the proteins have been characterized as being 
mitochondrial or have been removed.Page 5 of 9
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proteins are listed in MitoCarta as mitochondrial. The val-
ues obtained clearly demonstrate, that our strategy using
a selection based both on the presence of a mitochondrial
presequence and identifiable protein domains is very effi-
cient for extracting hypothetical proteins with a functional
role in mitochondria. Applying the selection strategy on
the 2006 dataset identified 24 of 67 proteins that later
have been categorized as mitochondrial. Furthermore the
percentage of removed proteins is 5-fold lower for group
III when compared with the 2006 dataset and the percent-
age of characterized proteins is concurrently 2.5 fold
higher. When investigating group II and group I proteins,
selected by our strategy it is evident that the percentage of
removed proteins is diminished to 9% and 5% respec-
tively, and the percentage of characterized proteins is
increased to 65% and 64% respectively. The prevalence of
mitochondrial proteins within the number of character-
ized proteins increases from 6% for the total 2006 dataset
to 45%, 58% and 85% for group III, group II and group I
respectively.
When increasing the selectivity of the applied prediction
models, in our case by focusing on group II and especially
group I proteins, it is evident that the probability of find-
ing hypothetical proteins, which will have a function in
the predicted sub-cellular compartment is increased.
However, it is also evident that the higher the selectivity,
the lower the total number of identified proteins with the
desired functionality. For group III proteins, 24 out of a
total of 67 mitochondrial proteins were discovered. For
group I, only 11 proteins out of the 67 mitochondrial pro-
teins were discovered.
The three groups of investigated proteins contain a total of
36 proteins that in November 2008 was still annotated as
hypothetical. According to our selection strategy, these
proteins are predicted to be expressed and to have roles in
a mitochondrial context. To investigate the potential of
these proteins, we investigated the protein domains of 6
hypothetical proteins of group I to see if they would sug-
gest a mitochondrial function for the relevant protein
(Table 4). 4 out of the 6 proteins each contain one
domain that are experimentally characterized in mito-
chondria and therefore may have putative mitochondrial
functions. The four domains were found to be a Complex
I-Lyr domain, a Methyltransferase 12 domain, a Sel 1
domain and a DUF1640 domain. The Complex I-LYR
domain is present in a family of proteins including the
mitochondrial NADH-ubiquinone oxidoreductase com-
plex I. The methyltransferase 12 domain is found in a vari-
ety of methyltransferases including one functioning in
mitochondria. Sel I like repeats domain is found in a vast
amount of proteins including HSP70, HSP90, and in the
mitochondrial Tom 70 import receptor. The DUF1640
domain is present in the mitochondrial protein FMP32
found in Saccharomyces cerevisiae. [26-30]
To demonstrate that the effectiveness of our in vitro select-
ing strategy is not dependent on neither TargetP nor the
SMART program, MITOPRED and WoLF PSORT replaced
TargetP and was together with the SMART program, used
Table 4: Identified protein domains of 6 hypothetical proteins
Accession Domain Description of protein domains
NP_001036096 Complex-1-LYR This hypothetical protein contains a Complex-1-LYR domain. The domain is present in a family of proteins, 
which include mitochondrial proteins from NADH-ubiquinone oxidoreductase complex 1. The domain is also 
present in the Saccharomyces cerevisiae protein Isd11, which is located in the mitochondrial matrix associated 
with the inner membrane. Isd11 protein is a subunit of the mitochondrial Fe/S protein biogenesis [26,27]
NP_077025 Methyltransf 12 Methyltransferase 12 domain is present in proteins, which actively transfer methyl from ubiguitous S-adenosyl-
L-methionine (SAM) to nitrogen, oxygen or carbon. This methyltrasferase domain is found in a variety of SAM-
dependent methyltransferases including Coq3 methyltransferase, which is a mitochondrial protein involved in 
ubiquinone biosynthesis. Coq3 protein is located in the matrix of the mitochondria [28,31,32]
NP_055588 Sel1 Sel1 like repeats are tetratricopeptide repeats (TPR) identified in LIN-12 proteins of Caenorhabditis elegans as a 
negative regulator of the Notch pathway [33] TPR-repeats are found in a variety of proteins including 
eukaryotic chaperone complexes involving HSP70 and HSP90, and TPRs are also present in the mitochondrial 
Tom70 import receptor [29,30]
EAW75090 DUF1640 DUF1640 domain is found in proteins of unknown functions. In Saccharomyces cerevisiae a protein containing 
the domain is named FMP32 (Found in mitochondrial proteome protein 32) and was localized to the 
mitochondria. [uniprot.org]
NP_612455 DUF143 DUF143: This domain has no known function and is found in the iojap protein of maize. The protein has no 
known function [34]
EAW74251 Trm112p Trm112p is a zinc finger domain found in the TRM112 protein that is required for tRNA methylation in 
Saccharomyces cerevisae. [35]
Description of protein domains identified in 6 hypothetical proteins of Group I, predicted to be expressed and to have a role in a mitochondrial 
context. In 4 out of 6 proteins, the identified protein domains have been described in experimentally characterized proteins of the mitochondria 
(First 4 domains).Page 6 of 9
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2006 dataset for proteins predicted to be mitochondrial.
Similarly, the SMART program was replaced by Prosite
and was together with TargetP used as basis for our selec-
tion strategy in order to screen a selection of the 2006
dataset (See Additional file 1). Using MITOPRED to
screen the 2006 dataset, 807 out of 5860 proteins were
predicted to be mitochondrial. Of the 807 proteins, 394
(49%) have been removed, 164 (20%) have been charac-
terized and 35 of these (21%) have been characterized as
mitochondrial. Using a combination of MITOPRED and
the SMART program, 198 out of 5860 proteins were pre-
dicted to be mitochondrial. Of the 198 proteins, 16 (8%)
have been removed, 113 (57%) have been characterized
and of these 28 (25%) have been characterized as mito-
chondrial (Table 5).
Using WoLF PSORT to screen the 2006 dataset, 754 out of
5860 proteins were predicted to be mitochondrial. Of the
754 proteins, 199 (26%) have been removed, 123 (16%)
have been characterized and 31 (25%) of these have been
characterized as mitochondrial. Using a combination of
WoLF PSORT and the SMART program, 154 out of 5860
proteins were predicted to be mitochondrial. Of the 154
proteins, 11 (7%) have been removed, 94 (61%) have
been characterized and 26 of these (28%) have been char-
acterized as mitochondrial (Table 5). Using MITOPRED
or WoLF PSORT alone to screen the 2006 dataset, respec-
tively 35 and 31 of the total of 67 mitochondrial proteins
were identified. However, both MITOPRED and WoLF
PSORT did also select 394 proteins that after 2006 have
been removed by GenBank. As was the case with TargetP,
MITOPRED and WoLF PSORT are efficient in finding
mitochondrial proteins, but they are not alone suitable
for screening hypothetical proteins for novel translatable
candidates. By replacing TargetP with either MITOPRED
or WoLF PSORT, our selection strategy is able to identify
26 to 31 of the total number of 67 proteins listed in Mito-
Carta as characterized mitochondrial proteins. Only 7-8%
of the proteins have been removed and the remainder is
either characterized or still hypothetical. This demon-
strates the efficiency of our in silico selection strategy using
MITOPRED or WoLF PSORT is comparable to our selec-
tion strategy using TargetP.
Of the proteins identified by our selection strategy based
on TargetP, up to 85% of the proteins that have been char-
acterized have been characterized as mitochondrial. For
our selection strategy based on MITOPRED or WoLF
PSORT, the corresponding values are 25% and 28%
respectively. The specificity of our selection strategy is
therefore dependent on the method of localization pre-
diction used. TargetP relies on the presence of well-
defined mitochondrial presequences, whereas MITO-
PRED and WoLF PSORT rely on putative Pfam domains
and signaling motifs.
The SMART program was replaced with the Prosite predic-
tion tool, which together with TargetP was used in our
selection strategy to analyze a subset of the 2006 dataset.
TargetP predicted 52 of the 5860 proteins to belong to
reliability class A. 15 of the 52 proteins have been
removed and 14 of the 52 proteins have been character-
ized as mitochondrial. Only 9 of the 52 proteins were by
Prosite found to contain known protein domains. 1 of the
9 proteins is still annotated as being hypothetical, while 8
of the found proteins have been characterized as mito-
chondrial. Prosite was therefore able to identify 8 of the
14 mitochondrial proteins present in the subsection of the
2006 dataset predicted by TargetP to be in reliability class
A and furthermore, none of the removed proteins were
selected by Prosite. In comparison, the SMART program
Table 5: Validation of selection strategy using a variety of prediction tools
Group Resulting proteins Hypothetical 
proteins
Characterized 
proteins
Removed proteins Characterized 
mitochondrial 
proteins
TargetP + SMART
(Grp I)
20 30%
(6 of 20)
65%
(13 of 20)
5%
(1 of 20)
85%
(11 of 13)
TargetP + SMART
(Grp III)
100 36%
(36 of 100)
53%
(53 of 100)
11%
(11 of 100)
45%
(24 of 53)
MITOPRED + 
SMART
198 34%
(68 of 198)
57%
(113 of 198)
8%
(16 of 198)
25%
(28 of 113)
WoLF PSORT + 
SMART
154 31%
(48 of 154)
61%
(94 of 154)
7%
(11 of 154)
28%
(26 of 94)
TargetP + Prosite
(Reliability class A)
9 11%
(1 of 9)
89%
(8 of 9)
0% 100%
(8 of 8)
2006 dataset - 25%
(1455 of 5860)
21%
(1215 of 5860)
54%
(3190 of 5860)
6%
(67 of 1215)
Different combinations of prediction tools were used on either the whole 2006 dataset or parts of it, to demonstrate that our selection strategy 
can use a variety of prediction tools and is neither dependent on TargetP nor the SMART program.Page 7 of 9
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For the subset of proteins investigated, the efficiency of
our selection strategy base on Prosite is therefore compa-
rable with our selection strategy based on the SMART pro-
gram.
Conclusion
A hypothetical protein may have a, yet uncharacterized,
role in a biological context or simply be the predicted
result of a pseudogene and with no biological relevance.
In order to screen a dataset of hypothetical proteins, we
propose a simple selection strategy where proteins are
selected on the basis of well-characterized targeting pep-
tides and protein domains. We have utilized a database of
hypothetical proteins dating from 2006 and reviewed
their annotated status in 2008. Accordingly, we can verify
our selection strategy by reviewing the proteins that were
hypothetical in 2006, but have been experimentally char-
acterized by November 2008. We chose to screen for
hypothetical proteins predicted to be mitochondrial since
considerable amounts of work have been performed
within the last couple of years to build extensive databases
of the human mitochondrial proteome, summarized in
works like MitoCarta. From the 2006 dataset, 5860 hypo-
thetical proteins were identified, and from this dataset, we
used TargetP together with the SMART program to identify
100 proteins that we believe, have a high probability of
being expressed mitochondrial proteins, based on our
selection strategy. This list is not exhaustive as, for
instance, hypothetical proteins with mitochondrial inter-
nal targeting signals but no mitochondrial presequence,
were not considered. When compared to the 2008 dataset,
we found that 53 of the 100 hypothetical proteins pre-
dicted to be mitochondrial have now been characterized,
and 45% of those were found to be mitochondrial. In
comparison, only 6% of the characterized proteins from
the 2006 dataset have been categorized as mitochondrial
in the same time period. Increasing the selectivity of Tar-
getP increases the incidence of characterized mitochon-
drial proteins to 85%, but unfortunately decreases the
total number of mitochondrial proteins identified.
Investigating identified protein domains of 6 of the 36
hypothetical proteins predicted to be mitochondrial, we
found a subset of 4 proteins having a strong mitochon-
drial signature in their identified protein domains. It is
our opinion that these proteins are very interesting candi-
dates for further experimental characterizations.
In present work we have applied our selection strategy in
the search for human mitochondrial proteins using Tar-
getP and the SMART program. From the characterized pro-
teins we were able to verify the fidelity of our in silico
selection strategy.
By using different combinations of prediction tools, we
demonstrated that our selection strategy is general. The
possibility of selecting different prediction tools thereby
allows the identification of hypothetical proteins with a
high probability of having a role in any organelle com-
partment where the internal targeting signals are charac-
terized. Furthermore, many of the targeting signals and
identifiable protein domains that are valid in human
cells, are also valid in other eukaryotes. Our selection
strategy can therefore be applied on a wide array of organ-
isms.
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